254 related articles for article (PubMed ID: 1465616)
1. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.
Mizoguchi H; O'Shea JJ; Longo DL; Loeffler CM; McVicar DW; Ochoa AC
Science; 1992 Dec; 258(5089):1795-8. PubMed ID: 1465616
[TBL] [Abstract][Full Text] [Related]
2. T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.
Levey DL; Srivastava PK
J Exp Med; 1995 Oct; 182(4):1029-36. PubMed ID: 7561676
[TBL] [Abstract][Full Text] [Related]
3. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
Burgess KE; Yamamoto M; Prasad KV; Rudd CE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
[TBL] [Abstract][Full Text] [Related]
4. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
[TBL] [Abstract][Full Text] [Related]
5. Do structural changes of T cell receptor complex occur in tumor-bearing state?
Noda S; Nagata-Narumiya T; Kosugi A; Narumiya S; Ra C; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1995 Apr; 86(4):383-94. PubMed ID: 7775260
[TBL] [Abstract][Full Text] [Related]
6. Do tumor-altered T cells depress immune responses?
Travis J
Science; 1992 Dec; 258(5089):1732-3. PubMed ID: 1465609
[No Abstract] [Full Text] [Related]
7. Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors.
Salvadori S; Gansbacher B; Pizzimenti AM; Zier KS
J Immunol; 1994 Dec; 153(11):5176-82. PubMed ID: 7963575
[TBL] [Abstract][Full Text] [Related]
8. Specificity of signal transduction through CD16, TCR-CD3 and BCR receptor chains containing the tyrosine-associated activation motif.
Schumann G; Dasgupta JD
Int Immunol; 1994 Sep; 6(9):1383-92. PubMed ID: 7819147
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells.
Loeffler CM; Smyth MJ; Longo DL; Kopp WC; Harvey LK; Tribble HR; Tase JE; Urba WJ; Leonard AS; Young HA
J Immunol; 1992 Aug; 149(3):949-56. PubMed ID: 1353099
[TBL] [Abstract][Full Text] [Related]
10. Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients.
Kim CW; Choi SH; Chung EJ; Lee MJ; Byun EK; Ryu MH; Bang YJ
Pathobiology; 1999; 67(3):123-8. PubMed ID: 10394132
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor zeta/CD3-p59fyn(T)-associated p120/130 binds to the SH2 domain of p59fyn(T).
da Silva AJ; Janssen O; Rudd CE
J Exp Med; 1993 Dec; 178(6):2107-13. PubMed ID: 7504057
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules.
Liu J; Finke J; Krauss JC; Shu S; Plautz GE
Cancer Immunol Immunother; 1998 Jul; 46(5):268-76. PubMed ID: 9690455
[TBL] [Abstract][Full Text] [Related]
13. Sequential development of structural and functional alterations in T cells from tumor-bearing mice.
Correa MR; Ochoa AC; Ghosh P; Mizoguchi H; Harvey L; Longo DL
J Immunol; 1997 Jun; 158(11):5292-6. PubMed ID: 9164948
[TBL] [Abstract][Full Text] [Related]
14. Alteration of signal-transducing molecules in tumor-infiltrating lymphocytes and peripheral blood T lymphocytes from human colorectal carcinoma patients.
Choi SH; Chung EJ; Whang DY; Lee SS; Jang YS; Kim CW
Cancer Immunol Immunother; 1998 Feb; 45(6):299-305. PubMed ID: 9490199
[TBL] [Abstract][Full Text] [Related]
15. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.
Beyers AD; Spruyt LL; Williams AF
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2945-9. PubMed ID: 1372996
[TBL] [Abstract][Full Text] [Related]
16. p59fyn tyrosine kinase regulates p56lck tyrosine kinase activity and early TCR-mediated signaling.
Lee SK; Shaw A; Maher SE; Bothwell AL
Int Immunol; 1994 Oct; 6(10):1621-7. PubMed ID: 7826952
[TBL] [Abstract][Full Text] [Related]
17. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.
Koneru M; Schaer D; Monu N; Ayala A; Frey AB
J Immunol; 2005 Feb; 174(4):1830-40. PubMed ID: 15699109
[TBL] [Abstract][Full Text] [Related]
18. Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn).
Cooke MP; Abraham KM; Forbush KA; Perlmutter RM
Cell; 1991 Apr; 65(2):281-91. PubMed ID: 2015626
[TBL] [Abstract][Full Text] [Related]
19. 7,12-Dimethylbenz[a]anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T-cell line and increases tyrosine phosphorylation of phospholipase C-gamma 1, formation of inositol 1,4,5-trisphosphate, and mobilization of intracellular calcium.
Archuleta MM; Schieven GL; Ledbetter JA; Deanin GG; Burchiel SW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6105-9. PubMed ID: 8327490
[TBL] [Abstract][Full Text] [Related]
20. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation.
Raab M; Cai YC; Bunnell SC; Heyeck SD; Berg LJ; Rudd CE
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8891-5. PubMed ID: 7568038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
